Patients with late-onset rheumatoid arthritis face poorer physical outcomes and higher risks of death and malignancy, ...

Patients with early RA who did not require a biologic disease-modifying antirheumatic drug (DMARD) had a higher chance of ...

Objectives To assess the effect of treatment on haemostatic parameters in patients with early rheumatoid arthritis (RA).

Get a Free Sample PDF copy of the report @- https://reportocean.com/industry-verticals/sample-request?report_id=BWC95 ...

EVT-401 is under clinical development by Evotec and currently in Phase I for Rheumatoid Arthritis. According to GlobalData, Phase I drugs for Rheumatoid Arthritis have a 69% phase transition success ...

Rheumatoid arthritis (RA) is associated with a higher rate of heart failure subtypes, according to a study published online ...

CreaVax-RA is under the development for the treatment of rheumatoid arthritis. The therapeutic candidate is administered through injection. CreaVax-RA is a dendritic cells (DC) based DC-based cancer ...

Research from Western Australia shows rheumatoid arthritis patients have lower overall cancer incidence but higher risks for ...

USA: Results from a recent study presented at the American College of Rheumatology (ACR) Convergence 2024 in Washington, DC, ...

There is a bidirectional association between rheumatoid arthritis (RA) and chronic obstructive pulmonary disease (COPD), ...

AnaptysBio's rosnilimab faces significant competition and uncertainty. See why ANAB stock's future hinges on Feb 2025 Phase ...

The management of rheumatoid arthritis has seen tremendous changes over the past 25 years, since the increasing availability of biological disease-modifying antirheumatic drugs (DMARDs) with various ...